Advertisement

Topics

NYSE Euronext Company Profile

05:51 EDT 19th March 2019 | BioPortfolio

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.


News Articles [287 Associated News Articles listed on BioPortfolio]

P&G Announces Delisting of Its Shares from Euronext Paris

Regulatory News: The Procter Gamble Company (NYSE: P&G) ("P&G") announced today that it has requested the delisting of its shares from Euronext Paris (ISIN US7427181091) due to the very low tradin...

Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Websit

Oxurion NV trading under "OXUR" on NYSE Euronext Brussels Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation ...

Galapagos NV: Galapagos and AbbVie restructure CF collaboration

Mechelen, Belgium, Chicago, US; 24 October 2018; 22.02 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) and AbbVie, Inc (NYSE: ABBV) announce a restructuring of their cystic fib...

Voluntis and AstraZeneca Win Prestigious Prix Galien MedStartUp Award for 'Best Patient Engagement Technologies' for eCO

Regulatory News: Voluntis (Euronext Paris, Ticker: VTX ISIN: FR0004183960) (Paris:VTX), a company specialized in digital therapeutics, and AstraZeneca (NYSE: AZN) announced that they have been awa...

Erytech Pharma S.A.: Monatliche Information bezüglich der Gesamtzahl der Stimmrechte und der Aktien, die das Aktienkapital bilden - 31. August 2018

Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon - Frankreich Notiert an folgenden Märkten: Euronext Paris von Euronext (Marktsegment B - ISIN-Code: ...

Impfstoffproduzent Valneva verlässt Börse Wien - Handel nur in Paris

Der an der Wiener Börse und der Pariser Euronext gelistete österreichisch-französische Impfstoffspezialist Valneva will die Wiener Börse verlassen und seine Aktien nur noch an der Pariser Euronext...

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma

PARIS and TARRYTOWN, N.Y., Oct. 19, 2018 /PRNewswire/ -- Sanofi (EURONEXT: SAN) (NYSE: SNY) The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy ...

Erytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2018

LYON, France, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon - France Listing markets: Euronext Paris from Euronext DateTotal o....

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Learning zero-cost portfolio selection with pattern matching.

We replicate and extend the adversarial expert based learning approach of Györfi et al to the situation of zero-cost portfolio selection implemented with a quadratic approximation derived from the mu...

Clinical Trials [0 Results]

None

Companies [620 Associated Companies listed on BioPortfolio]

NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trad...

Euronext N.V

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The ...

sanofi-pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

Sanofi Pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

Sanofi SA

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

More Information about "NYSE Euronext" on BioPortfolio

We have published hundreds of NYSE Euronext news stories on BioPortfolio along with dozens of NYSE Euronext Clinical Trials and PubMed Articles about NYSE Euronext for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NYSE Euronext Companies in our database. You can also find out about relevant NYSE Euronext Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record